Dr Patterson will review the background to the pharmaceutical crisis and the different ways that companies are approaching the issues. The lecture will review both the research and development and business issues facing the industry and its inv

A Pharma perspective on healthcare needs and innovation in drug discovery

Jun 9th, 2009 57m 58s

The third Green Templeton Lecture 2009 explores how, by harnessing innovation to meet unmet medical needs, pharma companies can deliver significant value to patients, payers and shareholders. The Green Templeton Lectures 2009 explored the theme

Pharmaceutical Companies, Government and Society

Jun 4th, 2009 37m 8s

This lecture will explore, from a historical perspective, the relationship between an emerging pharmaceutical industry, the establishment of drug regulatory authorities, and - most recently - the development of health technology assessment.

Pharmaceutical Industry: Origin and Evolution

May 19th, 2009 55m 48s

Tilli Tansey, Professor of History of Modern Medical Sciences, University College London traces the evolution of the modern pharmaceutical industry from the mid nineteenth century to the final decades of the twentieth century. The strong focus

Rate